07Sep 2023
Genefitletics can now predict and detect chronic diseases and cancer

Genefitletics can now predict and detect chronic diseases and cancer

Genefitletics, a pioneering human microbiome startup, revolutionizes disease prediction and early detection. They've unveiled PREDIGLYM, India's inaugural model for forecasting insulin response by analyzing gut microbiota. This innovation empowers individuals to manage their health proactively. Genefitletics plans to develop similar models for predicting conditions like autism, PCOS, IBD, Parkinson's, chronic renal disease, anxiety, depression, and obesity. The company's PROTEBA platform uses at-home samples to assess gut and vaginal microbiomes, offering disease-modifying nutrition therapy. They've also bridged the dental health gap with an oral microbiome solution and are set to introduce customized toothpaste.

  • #family health

Like

Save

Share